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HIV genital shedding enhances HIV transmission to 
sexual partners.1  We investigated whether abnormal 
vaginal flora, including bacterial vaginosis (BV), are 
associated with cervical HIV-1 RNA expression among 
HIV-infected women in Mozambique.
METHODS
Women were enrolled from October 2007 to March 2008 
as part of an evaluation of reproductive tract infections 
among HIV-infected individuals registering for a first visit 
at one of two HIV care clinics in Mozambique: Xai Xai 
Provincial Hospital and Mavalane General Hospital.2 We 
collected demographic and clinical data, and plasma 
and vaginal specimens. Cervical lavage specimens 
were obtained by application of 10 ml of sterile saline 
to the cervix and collection from the posterior fornix 
after 3 minutes. Diagnosis of BV was based on Nugent’s 
criteria. Diagnoses of Trichomonas vaginalis, Chlamydia 
trachomatis, Neisseria gonorrhoeae and Mycoplasma 
genitalium were done by real-time multiplex polymerase 
chain reaction testing. HIV RNA levels were determined 
by nucleic acid sequence-based amplification assay, 
with a lower limit of detection of 40 copies/ml. Patients 
were treated according to the 2006 Mozambique Ministry 
of Health treatment guidelines and offered partner 
notification cards. The evaluation protocol, consent form 
and questionnaires were approved by Mozambique’s 
National Health Bioethics Committee and the CDC 
Institutional Review Board. 
Data were analysed using SAS version 9.2 (SAS 
Institute, Cary, NC). Nugent scores were categorised 
as normal (0 - 3), intermediate vaginal flora (4 - 6) and 
BV (7 - 10). Cervical HIV RNA was dichotomised as 
detectable (≥40 copies/ml) or undetectable. Women 
with detectable cervical HIV were compared with women 
without detectable cervical HIV by the chi-square or 
Fisher’s exact test for categorical variables, and the 
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O R I G I N A L A R T I C L E
Objectives. We investigated whether abnormal vaginal flora, including bacterial vaginosis (BV), are associated 
with detection of cervical HIV-1 RNA among HIV-infected women in Mozambique.
Methods. We obtained clinical data and vaginal specimens from HIV-infected women registering for their first visit 
at one of two HIV care clinics in Mozambique. We compared women with detectable cervical HIV viral load (≥40 
copies/ml) with women with undetectable cervical HIV.
Results. We enrolled 106 women. Women with abnormal vaginal flora (intermediate Nugent scores, 4 - 6) were 
more likely to have detectable cervical HIV RNA than women with normal vaginal flora (adjusted odds ratio 7.2 
(95% confidence interval 1.8 - 29.1), adjusted for CD4 count). Women with BV had a non-significantly higher 
likelihood of detectable cervical HIV than women with normal flora. 
Conclusions. Abnormal vaginal flora were significantly associated with cervical HIV expression. Further research 
is needed to confirm this relationship. 
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t-test for continuous variables. We used multivariable 
logistic regression models to test whether abnormal 
vaginal flora (intermediate vaginal flora or BV) were 
associated with detectable cervical HIV RNA. Plasma 
viral load, CD4 count, trichomoniasis and age were 
considered for inclusion; variables were excluded if they 
were not significant (p≥0.05) or disrupted the model’s 
goodness of fit (e.g. CD4 count was included in the final 
model and plasma viral load was not). Missing data were 
excluded from the analyses.
RESULTS
Of 258 women enrolled in the larger study, 106 agreed 
to have cervical lavage specimens collected; there were 
no significant differences between women who agreed 
and did not agree to cervical lavage. The mean age of 
the 106 participating women was 33 years and most of 
them were from Xai Xai (Table I). None of the women 
was receiving antiretroviral therapy. 
Lower CD4 counts (p=0.01) and abnormal vaginal 
flora (p=0.04) were associated with cervical HIV RNA 
detection (Table I). In multivariable logistic regression 
modelling, women with intermediate vaginal flora had 
higher odds of detectable cervical HIV RNA than women 
with normal vaginal flora (adjusted odds ratio (aOR) 
7.2 (95% confidence interval (CI) 1.8 - 29.1), adjusted 
for CD4 count). Women with BV had non-significantly 
higher odds of detectable cervical HIV RNA compared 
with women with normal vaginal flora (aOR 2.7 (95% CI 
   Detection of cervical HIV RNA
 N  Yes (N (%))  No (N (%))     p
Total 106 75 (71) 31 (29) --
Study site (N=106)
   Xai Xai 70 48 (69) 22 (31) 0.49
   Maputo 36 27 (75) 9 (25)
Education (N=84)
   No education 2 1 (50) 1 (50) 0.51
   Primary 66 45 (68) 21 (32)
   Secondary or mid-level 16 10 (63) 6 (37)
Marital status (N=81)
   Single 38 24 (63) 14 (37) 0.93
   Unmarried, in relationship 32 22 (69) 10 (31)
   Married 2 1 (50) 1 (50)
   Widowed 9 6 (67) 3 (33)
Prior antiretroviral therapy (N=84)
   Yes 1 0 (0) 1 (100) 0.15
   No 83 56 (67) 27 (33)
CD4 count (cells/µl) (N=106)
   <50 14 12 (86) 2 (14) 0.01
   50 - 199 31 25 (81) 6 (19)
   200 - 349 26 21 (81) 5 (19)
  ≥350 35 17 (49) 18 (51)
HIV-1 plasma viral load (copies/ml) (N=76)
   <10 000 12 5 (42) 7 (58) 0.06
   10 000 - 99 999 31 24 (77) 7 (23)
   ≥100 000 33 24 (73) 9 (27)
Abnormal vaginal flora categories* (N=106)
   Bacterial vaginosis 47 32 (68) 15 (32) 0.04
   Intermediate vaginal flora 34 29 (85) 5 (15)
   Normal vaginal flora 25 14 (56) 11 (44)
Mycoplasma genitalium† (N=103)
   Positive 14 9 (64) 5 (36) 0.62
   Negative 89 63 (71) 26 (29)
Trichomonas vaginalis† (N=103)
   Positive 54 41 (76) 13 (24) 0.16
   Negative 49 31 (63) 18 (37)
Chlamydia trachomatis† (N=103)
   Positive 1 1 (100) 0 (0) 0.51
   Negative 102 71 (70) 31 (30)
Neisseria gonorrhoeae† (N=103)
   Positive 1 1 (100) 0 (0) 0.51
   Negative 102 71 (70) 31 (30)  
*Diagnosed by Nugent’s criteria (normal 0 - 3, intermediate 4 - 6, bacterial vaginosis 7 - 10). 
†Diagnosed by polymerase chain reaction of vaginal specimens. 
TABLE I. CHARACTERISTICS OF ENROLLED WOMEN AND ASSOCIATION WITH DETECTION OF CERVICAL HIV RNA
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0.8 - 8.7), adjusted for CD4 count). Mean Nugent scores 
of women with detectable cervical HIV were comparable 
to those of women without detectable cervical HIV (5.7 
v. 5.3, p=0.64). 
Compared with women with plasma viral loads of 
≥100 000 copies/ml, women with plasma viral loads of 
<10 000 copies/ml more often had abnormal vaginal 
flora (58% v. 21%, p=0.049). On stratified analysis, 
there was a non-significant trend towards higher plasma 
viral load and cervical HIV RNA detection among women 
with normal Nugent’s scores or BV, yet there was no 
association between plasma viral load and cervical HIV 
among women with intermediate vaginal flora. 
CONCLUSIONS
We found positive associations between intermediate 
vaginal flora and BV and detection of cervical HIV 
RNA among HIV-infected women in Mozambique, 
suggesting that abnormal vaginal flora might enhance 
HIV genital viral shedding. Previously published work 
demonstrated associations between the presence of BV 
and detection of cervical HIV RNA,3,4 possibly because 
of immune activation.5  It was surprising that although 
intermediate vaginal flora were significantly associated 
with genital HIV expression, BV was not. It is possible 
that intermediate vaginal flora are more conducive to HIV 
viral shedding than BV, yet the explanatory mechanism 
is unclear. It is also possible that our study lacked 
adequate power to detect a significant association 
between BV and detectable cervical HIV due to a small 
sample size: this may be reflected in the wide confidence 
intervals. Limitations include that we did not control for 
menstrual cycle timing, contraceptive use, possible 
semen contamination of cervical specimens and herpes 
simplex viral infection, and cold-chain interruptions 
may have occurred. We did not find a clear overall 
association between plasma HIV viral load and cervical 
HIV expression, although the association may have 
been confounded by the presence of abnormal vaginal 
flora. Despite these limitations, these data suggest 
that abnormal vaginal flora might enhance HIV genital 
shedding and thus potentially enhance HIV transmission 
to sexual partners. Further research is needed to confirm 
this association.
This analysis has not been presented at scientific 
conferences or published elsewhere. External funding 
was not used to support this work.
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